New bradykinin antagonist drugs show pain relief without numbness
Johns Hopkins researcher Dr Solomon Snyder reports bradykinin antagonists relieve pain in lab animals by blocking bradykinin from activating pain nerves. Nova Pharmaceutical and University of Colorado collaborators plan human trials. experts caution they are not yet superior to standard analgesics but offer a different mechanism and potential use when traditional drugs fail.
MENTIONED IN THIS ARTICLE
New York
Solomon Snyder
Snyder
Johns Hopkins University School of Medicine
Baltimore
Howard Fields
University of California At
San Francisco
Also Mentioned on This Page
European Journal of Pharmacology
Larry Steranka
Nova Pharmaceutical Corp
Raymond Vavrek
John Stewart
University of Colorado School of Medicine
Nova
Caladium c
Wolfe
Ita
Ree
Boston
Triox Killer
Gilmour
Northrup King
Burpee
Fredonia
Boston Fern Reg
Bermuda
Abelia
Weed &I
Andrews Highwrews
Midland
West Schaubauer
Sat
Sun
Big Spring Midland
Texas